Wen Z - Search Results

1

More than just DNA damage: Pt(ΙΙ)-NHC complexes derived from 4,5-diarylimidazoles augment immunogenic cell death.

Tang L, Chang X, Shi J, Wen Z, Bi C, Liu W. Tang L, et al. Among authors: wen z. Eur J Med Chem. 2025 Jan 15;282:117014. doi: 10.1016/j.ejmech.2024.117014. Epub 2024 Nov 12. Eur J Med Chem. 2025. PMID: 39566241

2

Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases.

Lu Y, Ma X, Chang X, Liang Z, Lv L, Shan M, Lu Q, Wen Z, Gust R, Liu W. Lu Y, et al. Among authors: wen z. Chem Soc Rev. 2022 Jul 4;51(13):5518-5556. doi: 10.1039/d1cs00933h. Chem Soc Rev. 2022. PMID: 35699475 Review.

3

Tumor-Targeting NHC-Au(I) Complex Induces Immunogenic Cell Death in Hepatocellular Carcinoma.

Yang Z, Bian M, Lv L, Chang X, Wen Z, Li F, Lu Y, Liu W. Yang Z, et al. Among authors: wen z. J Med Chem. 2023 Mar 23;66(6):3934-3952. doi: 10.1021/acs.jmedchem.2c01798. Epub 2023 Feb 24. J Med Chem. 2023. PMID: 36827091

4

SERD-NHC-Au(I) complexes for dual targeting ER and TrxR to induce ICD in breast cancer.

Lu Y, Sheng X, Liu C, Liang Z, Wang X, Liu L, Wen Z, Yang Z, Du Q, Liu W. Lu Y, et al. Among authors: wen z. Pharmacol Res. 2023 Apr;190:106731. doi: 10.1016/j.phrs.2023.106731. Epub 2023 Mar 17. Pharmacol Res. 2023. PMID: 36933755 Free article.

5

Design, synthesis and biological evaluation of fluorinated selective estrogen receptor degraders (FSERDs) --- A promising strategy for advanced ER positive breast cancer.

Lu Y, Liu C, Wang X, Liu L, Zhao Z, Liang Z, Liu Y, Wen Z, Du Q, Liu W. Lu Y, et al. Among authors: wen z. Eur J Med Chem. 2023 May 5;253:115324. doi: 10.1016/j.ejmech.2023.115324. Epub 2023 Mar 30. Eur J Med Chem. 2023. PMID: 37019030

6

Simultaneous Activation of Immunogenic Cell Death and cGAS-STING Pathway by Liver- and Mitochondria-Targeted Gold(I) Complexes for Chemoimmunotherapy of Hepatocellular Carcinoma.

Li F, Wen Z, Wu C, Yang Z, Wang Z, Diao W, Chen D, Xu Z, Lu Y, Liu W. Li F, et al. Among authors: wen z. J Med Chem. 2024 Feb 8;67(3):1982-2003. doi: 10.1021/acs.jmedchem.3c01785. Epub 2024 Jan 23. J Med Chem. 2024. PMID: 38261008

7

Gold(I) complexes bearing EGFR-inhibiting ligands as anti-HCC agents through dual targeting of EGFR and TrxR.

Wang Y, Ma X, Chen X, Wen Z, Bi C, Xu Z, Liu W. Wang Y, et al. Among authors: wen z. Eur J Med Chem. 2025 Feb 5;283:117137. doi: 10.1016/j.ejmech.2024.117137. Epub 2024 Dec 4. Eur J Med Chem. 2025. PMID: 39693862

8

Two new arthroconidial yeast species from bark and pit mud in China.

Zhu HY, Wei YH, Guo LC, Wen Z, Hu S, Wang DQ, You XL, Fan ED, Yao SJ, Bai FY, Han PJ. Zhu HY, et al. Among authors: wen z. MycoKeys. 2025 Jan 28;113:57-72. doi: 10.3897/mycokeys.113.141799. eCollection 2025. MycoKeys. 2025. PMID: 39911477 Free PMC article.

9

COVID-19 vaccines as a game-changing tool? A corpus-based study of vaccine communication in People's Daily and The New York Times.

Wen Z, Liu M, Huan C. Wen Z, et al. Heliyon. 2025 Jan 17;11(2):e42082. doi: 10.1016/j.heliyon.2025.e42082. eCollection 2025 Jan 30. Heliyon. 2025. PMID: 39911436 Free PMC article.

10

Comparison of the efficacy and safety of GLP-1 receptor agonists on cardiovascular events and risk factors: A review and network meta-analysis.

An X, Sun W, Wen Z, Duan L, Zhang Y, Kang X, Ji H, Sun Y, Jiang L, Zhao X, Gao Q, Lian F. An X, et al. Among authors: wen z. Diabetes Obes Metab. 2025 Feb 5. doi: 10.1111/dom.16228. Online ahead of print. Diabetes Obes Metab. 2025. PMID: 39910752 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,699 results

Search Page

Filters